Good morning and welcome to Denison Form's daily article podcast.

It's Friday, June 20, 2025.

I'm Connor Jones, co-host of the Culture Brief podcast, filling in for Chris Elkins and narrating

today's daily article, authored by our senior editor for theology, Dr. Ryan Denison.

On Wednesday, the Supreme Court upheld Tennessee's ban on the use of hormone therapy and

puberty blockers for the treatment of transgender children.

The case, United States v. Scrimetti, was brought before the court on

the argument that the law was unconstitutional because it violated the rights of transgender

youth to equal protection. As Adam B. Kushner described in the New York Times, quote,

this case was a legal and political gamble that was rooted in uncertain science and contested ideas

about sex and gender. Yet despite the risks and the fact that the case was originally

contested under the Biden administration, the groups advocating for the continued medical

treatment of transgender kids believed support from the government, public opinion, and

recent rulings was enough to

buoy their case. They were wrong, and the potential implications could stretch well beyond the state

of Tennessee. Still, with a ruling this controversial, it's important to distinguish between

what's been reported in the headlines, which largely described the decision as some

form of a major

setback for transgender rights and what the court actually said. To that end, let's take a closer

look at their decision. While the final six to three decision fell along ideological lines,

the court did not take the matter lightly. As Chief Justice John Roberts noted, quote,

this case carries with it the

...